Detalles de la búsqueda
1.
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.
Cancer Immunol Immunother
; 72(1): 137-149, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771253
2.
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Cancer Immunol Immunother
; 69(3): 477-488, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31980913
3.
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
Ann Surg Oncol
; 26(12): 3945-3952, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30830540
4.
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.
Gynecol Oncol
; 153(1): 127-134, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30686551
5.
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
Breast Cancer Res
; 16(1): R13, 2014 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24467828
6.
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
Breast Cancer Res
; 16(1): R6, 2014 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24447434
7.
Case series: indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma.
BMC Cancer
; 14: 967, 2014 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515496
8.
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Nat Commun
; 15(1): 1632, 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395969
9.
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites.
BMC Cancer
; 13: 612, 2013 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24373320
10.
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients.
Oncoimmunology
; 11(1): 2015113, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36524210
11.
Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.
Oncoimmunology
; 11(1): 2094133, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35800157
12.
Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity.
Cancers (Basel)
; 13(9)2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34067105
13.
Whole Blood Transcriptome Profiling Identifies DNA Replication and Cell Cycle Regulation as Early Marker of Response to Anti-PD-1 in Patients with Urothelial Cancer.
Cancers (Basel)
; 13(18)2021 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34572887
14.
Spatial and Temporal Heterogeneity of Tumor-Infiltrating Lymphocytes in Advanced Urothelial Cancer.
Front Immunol
; 12: 802877, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35046958
15.
Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma.
Cancers (Basel)
; 13(15)2021 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359813
16.
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.
Breast Cancer Res Treat
; 120(3): 655-61, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20204499
17.
Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination.
Oncoimmunology
; 9(1): 1738814, 2020 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33457087
18.
[Pseudoprogression in immune therapy]. / Pseudoprogressie bij immuuntherapie.
Ned Tijdschr Geneeskd
; 1632019 07 05.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-31283128
19.
[Immunotherapy for cancer: from medical breakthrough to application in daily practice]. / Immuuntherapie voor kanker.
Ned Tijdschr Geneeskd
; 1632019 05 31.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-31187969
20.
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program.
J Immunother
; 42(6): 208-214, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31145233